Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Peptide Process CMCPeptide Process CMC
Not Confirmed
Not Confirmed
28-30 August, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Peptide Process CMCPeptide Process CMC
Industry Trade Show
Not Confirmed
28-30 August, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
28 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250728561286/en/Pluristyx-Completes-Investment-Round-to-Expand-Product-Portfolio-and-Commercial-Operations
12 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250612648308/en/Pluristyx-Launches-PluriForm-Organoid-Kit-Slashing-Weeks-Off-Organoid-Development-Timelines
19 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/19/3045322/0/en/Teknova-and-Pluristyx-Launch-Proprietary-PluriFreeze-Cryopreservation-System-to-Accelerate-the-Development-of-Cell-Therapies.html
11 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/11/3041067/0/en/Teknova-and-Pluristyx-Announce-Collaboration-to-Streamline-the-Manufacture-of-Next-Generation-Cell-Therapies.html
11 Feb 2025
// BUSINESSWIRE
04 Feb 2025
// BUSINESSWIRE
ABOUT THIS PAGE